Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers

Simple item page
dc.contributor.buuauthorÖzakın, Cüneyt
dc.contributor.buuauthorSınırtaş, Melda
dc.contributor.buuauthorSevgican, Emine
dc.contributor.buuauthorKazak, Esra
dc.contributor.buuauthorGedikoğlu, Suna
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı.tr_TR
dc.contributor.researcheridAAĞ-8459-2021tr_TR
dc.contributor.scopusid57200678942tr_TR
dc.contributor.scopusid6505818048tr_TR
dc.contributor.scopusid16246450600tr_TR
dc.contributor.scopusid24921238200tr_TR
dc.contributor.scopusid6603407548tr_TR
dc.date.accessioned2023-04-27T08:14:31Z
dc.date.available2023-04-27T08:14:31Z
dc.date.issued2003-10
dc.description.abstractSome automated systems used in clinical microbiology laboratories are able to detect products responsible for antimicrobial resistance. In this study, 626 isolates (436 Escherichia coli, 134 Klebsiella pneumoniae and 56 Klebsiella oxytoca strains) were examined for the presumptive detection of extended-spectrum beta-lactamase (ESBL) production by 2 methods: the Sceptor system (BD, Sparks, MD, USA) and the E-test. ESBL production was detected in 26 E. coli strains (5.96%), 60 K. pneumoniae strains (44.77%) and 15 K. oxytoca strains (26.78%) by ceftazidime/ceftazidime-clavulanate E-test. Using the E-test, ESBL production was detected in 25 of 201 E. coli strains (12.43%), 55 of 75 K. pneumoniae (73.33%) and 14 of 27 K. oxytoca strains (51.85%) that were alerted as ESBL-producing strains by the Sceptor system. ESBL positivity was detected in 1 E. coli, 5 K. pneumoniae and 1 K. oxytoca strains, that were not warned as being ESBL producers by the Sceptor system. These data suggest that clinical microbiology laboratories should not only rely on these rapid automated systems but also use another method for screening ESBL producers, such as the E-test. The rates of these ESBL-producing isolates in this study were lower than those in other studies reported from other parts of Turkey, but higher than those reported from the USA and Europe.en_US
dc.identifier.citationÖzakın, C. vd. (2003). “Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers”. Scandinavian Journal of Infectious Diseases, 35(10), 700-703.en_US
dc.identifier.endpage703tr_TR
dc.identifier.issn0036-5548
dc.identifier.issue10tr_TR
dc.identifier.pubmed14606607tr_TR
dc.identifier.scopus2-s2.0-0242351602tr_TR
dc.identifier.startpage700tr_TR
dc.identifier.urihttps://doi.org/10.1080/00365540310016006
dc.identifier.urihttps://www.tandfonline.com/doi/abs/10.1080/00365540310016006
dc.identifier.urihttp://hdl.handle.net/11452/32435
dc.identifier.volume35tr_TR
dc.identifier.wos000185887100001tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.journalScandinavian Journal of Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInfectious diseasesen_US
dc.subjectIntensive-care unitsen_US
dc.subjectKlebsiella-pneumoniaeen_US
dc.subjectEscherichia-colien_US
dc.subjectResistanceen_US
dc.subjectSurveillanceen_US
dc.subjectProgramen_US
dc.subjectStrainsen_US
dc.subjectStatesen_US
dc.subject.emtreeAnalytic methoden_US
dc.subject.emtreeAntibiotic resistanceen_US
dc.subject.emtreeAntibiotic sensitivityen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAutoanalysisen_US
dc.subject.emtreeBacterial strainen_US
dc.subject.emtreeBacterium identificationen_US
dc.subject.emtreeBacterium isolateen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeEnzyme synthesisen_US
dc.subject.emtreeEscherichia colien_US
dc.subject.emtreeEuropeen_US
dc.subject.emtreeIntermethod comparisonen_US
dc.subject.emtreeKlebsiella oxytocaen_US
dc.subject.emtreeKlebsiella pneumoniaeen_US
dc.subject.emtreeMicrobiological examinationen_US
dc.subject.emtreeMinimum inhibitory concentrationen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeScreening testen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeUnited Statesen_US
dc.subject.emtreeAntibiotic agenten_US
dc.subject.emtreeAztreonamen_US
dc.subject.emtreeBeta lactamaseen_US
dc.subject.emtreeCefotaximeen_US
dc.subject.emtreeCeftazidimeen_US
dc.subject.emtreeCeftriaxoneen_US
dc.subject.emtreeCephalosporinen_US
dc.subject.emtreeClavulanic aciden_US
dc.subject.meshAutomationen_US
dc.subject.meshBacterial typing techniquesen_US
dc.subject.meshBeta-lactamasesen_US
dc.subject.meshCephalosporinsen_US
dc.subject.meshDrug resistance, bacterialen_US
dc.subject.meshEscherichia colien_US
dc.subject.meshEscherichia coli infectionsen_US
dc.subject.meshHumansen_US
dc.subject.meshKlebsiellaen_US
dc.subject.meshKlebsiella infectionsen_US
dc.subject.meshMicrobial sensitivity testsen_US
dc.subject.scopusBeta Lactamase; Anti-Bacterial Agents; Enterobacteriaceaeen_US
dc.subject.wosInfectious diseasesen_US
dc.titleComparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producersen_US
dc.typeArticle

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
Scopus